Stephen D. Silberstein, MD  Chairman
Thomas Jefferson University, Philadelphia, PA, USA

Dr. Silberstein is Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University. He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as president, treasurer, and member of the board of directors. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-chair of the Annual Scientific Meeting. Dr. Silberstein is an active member of the American Academy of Neurology and is Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He is Chair of the Headache Research Group of the World Federation of Neurology.

Dr. Silberstein received his medical degree from the University of Pennsylvania. He did a medical internship at the Hospital of the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein completed a medicine/neurology residency at the Hospital of the University of Pennsylvania. He served as a pharmacology research associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health, and completed a neurology residency at the Hospital of the University of Pennsylvania.

Dr. Silberstein is Senior Editor of the 8th edition of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the editorial boards of Headache, Cephalalgia, Acta Neurologica Scandinavica, Journal of Neurology, Neurosurgery & Psychology, and Topics in Pain Management. He is an ad hoc reviewer for many publications, including The New England Journal of Medicine, Brain, The Lancet, JAMA, Mayo Clinic Proceedings, Annals of Neurology, and Neurology.

Dr. Silberstein has more than 300 peer-reviewed publications to his credit and lectures extensively on the pathogenesis, neurobiology, diagnosis, and treatment of headache.


Amaal J. Starling, MD
Mayo Clinic, Phoenix, AZ

Dr. Amaal J. Starling is an Assistant Professor of Neurology in the Mayo Clinic College of Medicine. She joined Mayo in 2012 and is currently a Consultant within the Department of Neurology.

Dr. Starling received her M.D. degree from the Drexel University College of Medicine in Philadelphia. She completed a Transitional Year Residency, a Neurology Residency, and a Headache Fellowship at the Mayo Clinic College of Medicine in Scottsdale, Arizona.

She is an active member of the American Academy of Neurology, the American Headache Society (AHS), the American Medical Association and the American Pain Society. She is the Co-Chair of the American Headache and Migraine Association, Chair of the New Investigator and Trainee special interest section of the AHS, and serves as a member of the AHS Annual Meeting Scientific Committee. She is a perennial speaker at the AHS Annual Meeting in Scottsdale, Arizona. Dr. Starling has been the recipient of numerous awards including the AHS Above and Beyond Award for Service, Manfred D. Muenter Award for Excellence in Clinical Neurology, the American Academy of Neurology Annual Meeting Residency Scholarship, the 2012 Spirit of Mayo Clinic Award, and the Mayo Brothers Distinguished Fellowship Award.

Dr. Starling has several peer-reviewed publications and abstracts related to her fields of interest which include migraine, concussion, posttraumatic headache, trigeminal autonomic cephalalgias, secondary headaches, telemedicine and teleconcussion, neurology resident education, and professionalism and clinical ethics.


Peter J. Goadsby, MD
King’s College of London, London, UK

Dr. Goadsby obtained his basic medical degree and training at the University of New South Wales, Australia. His neurology training was done under the supervision of Professor James W. Lance in Sydney. After post-doctoral work in New York with Don Reis at Cornell, with Jacques Seylaz at Université VII, Paris, and post-graduate neurology training at Queen Square in London with Professors C. David Marsden, Andrew Lees, Anita Harding, and W. Ian McDonald, he returned to the University of New South Wales, and the Prince of Wales Hospital, Sydney, as Consultant Neurologist and was promoted to Associate Professor of Neurology.

He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is now Director of the Wellcome Trust Clinical Research Facility at King’s College, London, and remains Honorary Consultant Neurologist at the Hospital for Sick Children at Great Ormond Street, London. His major research interests are in the basic mechanisms of head pain in both experimental settings and in the clinical context of headache management. The work of the Headache Group involves human imaging and electrophysiological studies in primary headache, as well as experimental studies of trigeminovascular nociception. The aim is to understand what parts of the brain drive and modulate headache syndromes, and how those might be modified by treatment.

Dr. Goadsby has authored more than 500 peer-reviewed publications and co-authored nine books, and is on the editorial board of several journals, including Annals of Neurology, Neurology, European Journal of Neurology, and Acta Neurologica Scandinavica. He is Immediate Past President of the International Headache Society, Scientific Advisor of European Headache and Migraine Trust, American Migraine Foundation, Chair of the British Association for the Study of Headache, and Chair of the American Headache Society Annual Scientific Meeting Committee.


David W. Dodick, MD, FRCP (C), FACP
Mayo Clinic, Phoenix, AZ

Dr. Dodick is Professor of Neurology at the Mayo Clinic College of Medicine and Science, and a Consultant in neurology at the Mayo Clinic in Scottsdale, Arizona. He is Program Director of the Mayo Clinic Neurology Residency Program and Headache Medicine Fellowship Program. He is Medical Director of the Headache Program as well as the Concussion Program at Mayo Clinic in Arizona.

Dr. Dodick received a medical degree with distinction from Dalhousie University in Halifax, Nova Scotia. He completed an internship and a neurology residency at the Mayo Clinic in Rochester, Minnesota, followed by fellowship training at the University of Toronto in Ontario. Dr. Dodick is board-certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology.

Dr. Dodick has authored more than 280 peer-reviewed publications and co-authored eight books. He serves as Editor-in-Chief of Cephalalgia and is on the editorial board of several journals, including The Neurologist, Postgraduate Medicine, and Lancet Neurology. Dr. Dodick is President-elect of the International Headache Society. He is Immediate Past President of the American Headache Society, Chair of the American Migraine Foundation, and Vice Chair of the World Federation of Neurology Headache Research Group.


Thomas C. Chelimsky, MD
Chairman and Professor of the Department of Neurology
Medical College of Wisconsin
Milwaukee, Wisconsin

Dr. Chelimsky is Chair and Professor of the Department Of Neurology for the Medical College of Wisconsin. Dr. Chelimsky was previously Professor of Neurology, Anesthesiology, and Pediatrics at Case Western Reserve University School of Medicine in Cleveland where he served as Director of the Division of Autonomic Disorders at University Hospitals of Cleveland. A graduate of Harvard University (undergraduate) and Washington University (medicine), Dr. Chelimsky completed residencies in internal medicine and neurology, as well as a fellowship in autonomic research, at the Mayo Clinic in Rochester, Minnesota. Dr. Chelimsky joined the faculty at Case Western in 1990 and rose to the rank of Professor in 2007. He has also directed the University Hospitals of Cleveland Pain Center.

An accomplished researcher, Dr. Chelimsky has published 41 original articles, contributed to 23 books or chapters, and made 36 invited scientific and clinical presentations to regional and national colleagues. A National Institutes of Health-funded investigator with two active awards, he has received public and foundation support for nearly 20 years. His work has focused on the interface between autonomic dysfunction and chronic pain, and his current research focuses on a broad epidemiologic approach to assess genetic links across several autonomic/pain disorders, including migraine headaches, fibromyalgia, irritable bowel syndrome, and interstitial cystitis. He also works closely with his wife, Dr. Gisela Chelimsky, a pediatric gastroenterologist, on pediatric functional disorders. Dr. Chelimsky is a highly experienced teacher and mentor of medical students, fellows and junior faculty members as well as an accomplished physician. He was listed as one of the Best Doctors in America™ yearly since 2001. He has served as the chair of both Autonomic and Pain Sections of the American Academy of Neurology where he directs the primary course on Autonomic Disorders for neurologists.


Irina A. Anselm, MD
Director of the Mitochondrial Program and Co-Director of the Neurometabolic Program
Boston Children’s Hospital
Boston, Massachusetts

Irina A. Anselm, MD, is Director of the Mitochondrial Program and Co-Director of the Neurometabolic Program at Boston Children’s Hospital. A pediatric neurologist with special interest in genetics and hereditary disorders, she cares for children with neurometabolic, neurodegenerative, and mitochondrial disorders. Her research focuses on the genetics, diagnosis, and management of these disorders, which range from mild to devastating. She is the Principal Investigator of a study investigating the use of experimental drug dichloroacetate (DCA) as a treatment for chronic elevation of blood lactate levels resulting from mitochondrial disorders. Major publications include 20 original reports in peer-reviewed journals and 4 chapters, and she is a reviewer for the Journal of Pediatric Neurology, Current Pediatric Reviews, and the Journal of Child Neurology.

Dr. Anselm serves as an expert for the Department of Neurology for Boston Children’s Hospital Precision Medicine Service.